The ring-opening polymerization of ε-caprolactone has been initiated by [tris(hexamethyldisilyl)amide]yttrium in the presence of an excess of 2-propanol. This initiating system is very active
even at high alcohol-to-Y molar ratio. Polymers with controlled molecular parameters (M
n, end groups)
and low dispersity are formed as result of fast alkoxide/alcohol exchange. At molar excess of 2-propanol
higher than 100, this exchange is no longer quantitative. The in situ formed active species involved in
this new initiating system are different from those ones present in the commercial yttrium oxo-isopropoxide
Y5(μ-O)(OiPr)13 cluster. Evidence is provided by 1H NMR spectroscopy.
[Tris(hexamethyldisilyl)amide] yttrium is a catalyst for the controlled ring-opening polymerization of ε-caprolactone when reacted with an excess of alcohol. Up to an alcohol-to-yttrium molar
ratio of 50, the chain transfer to the alcohol is quantitative, and the molecular weight of the chains can
be predicted from the monomer-to-alcohol molar ratio. At alcohol-to-yttrium ratios higher than 100, the
alcohol is quantitatively consumed provided that 1,1,1,3,3,3-hexamethyldisilazane, which is formed as a
byproduct, is removed from the reation medium. Depending on the structure of the alcohol, end-functional
polyesters can be prepared (e.g., with N-pyrrolyl and 3-thienyl end groups). Well-defined block and random
copolymers of ε-CL with lactides and γ-bromo-ε-caprolactone, respectively, have also been synthesized.
Compared to aluminum alkoxides, the in situ formed yttrium alkoxides have the advantage of a much
faster polymerization kinetics while preserving control.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.